Osteocalcin, Serum
Osteocalcin is the major non-collagen calcium binding protein and it is excreted by osteoblasts in the bone. The serum concentrations are an indication of bone formation. The synthesis of osteocalcin is vitamin D independent. Elevated results are usually associated with increased bone turnover such as what is seen in osteoporosis. Bisphosphonated drugs used to treat osteoporosis can be monitored for effectiveness by measuring osteocalcin levels. Levels are normally high in childhood and then peak in early puberty. During menopause a second peak usually occurs in females.
Although results are not strictly diagnostic of osteoporosis, a decrease in the value can be interpreted as evidence of a favorable response to treatment. Patients that are on vitamin K antagonist medication can have unreliable results. Therefore, ELISA methodology is the best choice to test for undercarboxylated osteocalcin. This assay should be used in conjunction with other bone markers for best interpretation. Bone mineral densitometry and imaging studies are the gold standard for the evaluation of osteoporosis. Bone formation/ resorption may be accurately reflected in patients taking 1,25-dihydroxyvitamin D or if there is an abnormality with it.
Of note, bone formation and serum Osteocalcin level follows a diurnal rhythm and is also subject to the menstrual cycle. Variation by as much as 50% can be seen from a nocturnal peak to a morning low, with a 10% day to day variation, and as large as a 60% increase can be seen following a fracture.
- As an aid in monitoring mineral and bone metabolism
- Determine efficacy of therapy in osteoporosis and metastatic bone disease
- Monitoring bone metabolic changes secondary to Cushing syndrome
- Monitoring bone metabolic changes secondary to primary hyperparathyroidism
- Monitoring bone metabolic changes secondary to malabsorption syndrome
- As an aid in diagnosis of plasma cell myeloma
- Selection of therapy for patients with hypercalciuria
Increased in:
- Primary or secondary osteoporosis
- Osteomalacia
- Osteopenia due to vitamin D deficiency
- Growth hormone deficiency
- Hypogonadism
- Paget’s disease
- Osteoporosis
- Cushing syndrome
- Renal osteodystrophy
- Inflammatory states such as rheumatoid arthritis
- Bone metastasis
- Hyperthyroidism
- Primary Hyperparathyroidism
- Myeloma
- Hypercalciuria
- Children
- Long term corticosteroid use
- Acromegaly
- Recent bone fracture
- Menopause
- Lactation
- Excercise
- Incresed age
Decreased in:
- Decreased results may indicate favorable therapeutic response
- Pregnancy
- Growth hormone deficiency
- Hypothyroidism
- Hypoparathyroidism
- Liver disease
- Alcoholism
- Long term corticosteroid therapy
- Obesity
- Type 2 Diabetes
| Age / Sex | ng/mL or µg/L |
| Child 6–9.9 yr | 40.2–108 |
| 10–13.9 yr | 35.8–166 |
| 14–17.9 yr Male | 27.8–194 |
| 14–17.9 yr Female | 16.3–68.7 |
| Adult Male | 11.3–35.4 |
| Adult Male | 1.1–7.2 |
| Female, Premenopausal | 0.5–7.0 |
Chemiluminescent immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).
Serum Red top preferred, Serum gel(SST) acceptable.
Must be fasting.
Separate within 1 hour and freeze.
| ICD10 Code and Description | LCD Code | NCD Code |
|---|---|---|
| No results found matching your search criteria. | ||
| ICD10 Code and Description | LCD Code | NCD Code |
|---|---|---|
| No results found matching your search criteria. | ||
- JAMA. 2001; 285:785-95. [PMID: 11176917]
- Clin Calcium. 2009 Dec;19(12):1815-21. [PMID: 19949273]
- J Cell Biochem. 1995 Mar;57(3):379-83. [PMID: 7768973]
- Clin Orthop Relat Res. 1988 Jan;(226):267-91. [PMID: 3275514]
- Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757